Skip to main content

20.04.2024 | Original Paper

Emotional and functional well-being in long-term breast cancer survivorship

verfasst von: Yumeng Ren, Joanna Maselko, Xianming Tan, Andrew F. Olshan, Angela M. Stover, Antonia V. Bennett, Katherine E. Reeder-Hayes, Jessie K. Edwards, Bryce B. Reeve, Melissa A. Troester, Marc A. Emerson

Erschienen in: Cancer Causes & Control

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Emotional and functional well-being (EWB and FWB) are important components of mental health and quality of life. This study aims to evaluate long-term EWB and FWB in breast cancer (BC) survivors.

Methods

The Carolina Breast Cancer Study Phase 3 oversampled Black and younger (< 50 years in age) women so that they each represent approximately 50% of the study population and assessed participants’ EWB and FWB with the Functional Assessment of Cancer Therapy—Breast (FACT-B) at 5- (baseline), 25-, and 84-months post diagnosis. Multinomial logit models were used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for associations between demographic and clinical characteristics and well-being change relative to baseline.

Results

Among 2,781 participants with BC, average EWB and FWB improved with time since diagnosis. Persistent FWB decrements were associated with Black race [OR 1.4 (95% CI 1.2–1.7) and 1.3 (95% CI 1.1–1.6), at 25-months and 84-months respectively], older age [OR 1.4 (95% CI 1.1–1.7) and 1.5 (95% CI 1.2–1.8), respectively], no chemotherapy, and recurrence [OR 2.9 (95% CI 1.8–4.8) and 3.1 (95% CI 2.1–4.6), respectively]. EWB decrements were associated with advanced stage and recurrence. Decrements in combined (FWB+EWB) well-being were associated with recurrence at both follow-up survey timepoints [ORs 4.7 (95% CI 2.7–8.0) and 4.3 (95% CI 2.8–6.6), respectively].

Conclusions

Long-term well-being varies by demographics and clinical features, with Black women and women with aggressive disease at greatest risk of long-term decrements.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33PubMedCrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33PubMedCrossRef
2.
Zurück zum Zitat Narod SA, Iqbal J, Miller AB (2015) Why have breast cancer mortality rates declined? J Cancer Policy 5:8–17CrossRef Narod SA, Iqbal J, Miller AB (2015) Why have breast cancer mortality rates declined? J Cancer Policy 5:8–17CrossRef
3.
Zurück zum Zitat American Cancer Society (2019) Cancer treatment & survivorship facts & figures 2019–2021. American Cancer Society, Atlanta, GA American Cancer Society (2019) Cancer treatment & survivorship facts & figures 2019–2021. American Cancer Society, Atlanta, GA
4.
Zurück zum Zitat Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351PubMedCrossRef Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351PubMedCrossRef
5.
Zurück zum Zitat Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28PubMedCrossRef Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28PubMedCrossRef
6.
Zurück zum Zitat Massie MJ (2004) Prevalence of depression in patients with cancer. JNCI Monogr 2004(32):57–71CrossRef Massie MJ (2004) Prevalence of depression in patients with cancer. JNCI Monogr 2004(32):57–71CrossRef
7.
Zurück zum Zitat World Health Organization (2004) Promoting mental health: Concepts, emerging evidence, practice: summary report. World Health Organization, Geneva World Health Organization (2004) Promoting mental health: Concepts, emerging evidence, practice: summary report. World Health Organization, Geneva
9.
Zurück zum Zitat Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84(8):1011–1015PubMedPubMedCentralCrossRef Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84(8):1011–1015PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat von Heymann-Horan AB, Dalton SO, Dziekanska A et al (2013) Unmet needs of women with breast cancer during and after primary treatment: a prospective study in Denmark. Acta Oncol 52(2):382–390CrossRef von Heymann-Horan AB, Dalton SO, Dziekanska A et al (2013) Unmet needs of women with breast cancer during and after primary treatment: a prospective study in Denmark. Acta Oncol 52(2):382–390CrossRef
11.
Zurück zum Zitat Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405PubMedCrossRef Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405PubMedCrossRef
12.
Zurück zum Zitat Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH (2015) The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas 82(1):100–108PubMedCrossRef Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH (2015) The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas 82(1):100–108PubMedCrossRef
13.
Zurück zum Zitat Carreira H, Williams R, Müller M, Harewood R, Stanway S, Bhaskaran K (2018) Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. J Natl Cancer Inst 110(12):1311–1327PubMedPubMedCentralCrossRef Carreira H, Williams R, Müller M, Harewood R, Stanway S, Bhaskaran K (2018) Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. J Natl Cancer Inst 110(12):1311–1327PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Janz NK, Mujahid MS, Hawley ST et al (2009) Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv 3(4):212–222PubMedCrossRef Janz NK, Mujahid MS, Hawley ST et al (2009) Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv 3(4):212–222PubMedCrossRef
15.
Zurück zum Zitat Rao D, Debb S, Blitz D, Choi SW, Cella D (2008) Racial/ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manag 36(5):488–496CrossRef Rao D, Debb S, Blitz D, Choi SW, Cella D (2008) Racial/ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manag 36(5):488–496CrossRef
16.
Zurück zum Zitat Ashing-Giwa KT, Lim J-W (2011) Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum 38(3):279–288PubMedCrossRef Ashing-Giwa KT, Lim J-W (2011) Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum 38(3):279–288PubMedCrossRef
17.
Zurück zum Zitat Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH (2004) Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med 28(1):39–51PubMedCrossRef Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH (2004) Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med 28(1):39–51PubMedCrossRef
18.
Zurück zum Zitat Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21(22):4184–4193PubMedCrossRef Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21(22):4184–4193PubMedCrossRef
19.
Zurück zum Zitat Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033PubMedCrossRef Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033PubMedCrossRef
20.
Zurück zum Zitat Janz NK, Friese CR, Li Y, Graff JJ, Hamilton AS, Hawley ST (2014) Emotional well-being years post-treatment for breast cancer: prospective, multi-ethnic, and population-based analysis. J Cancer Surviv 8(1):131–142PubMedCrossRef Janz NK, Friese CR, Li Y, Graff JJ, Hamilton AS, Hawley ST (2014) Emotional well-being years post-treatment for breast cancer: prospective, multi-ethnic, and population-based analysis. J Cancer Surviv 8(1):131–142PubMedCrossRef
21.
Zurück zum Zitat Clough-Gorr KM, Ganz PA, Silliman RA (2007) Older breast cancer survivors: factors associated with change in emotional well-being. J Clin Oncol 25(11):1334–1340PubMedCrossRef Clough-Gorr KM, Ganz PA, Silliman RA (2007) Older breast cancer survivors: factors associated with change in emotional well-being. J Clin Oncol 25(11):1334–1340PubMedCrossRef
22.
Zurück zum Zitat Rottmann N, Dalton SO, Christensen J, Frederiksen K, Johansen C (2010) Self-efficacy, adjustment style and well-being in breast cancer patients: a longitudinal study. Qual Life Res 19(6):827–836PubMedCrossRef Rottmann N, Dalton SO, Christensen J, Frederiksen K, Johansen C (2010) Self-efficacy, adjustment style and well-being in breast cancer patients: a longitudinal study. Qual Life Res 19(6):827–836PubMedCrossRef
23.
Zurück zum Zitat McGee SA, Durham DD, Tse C-K, Millikan RC (2013) Determinants of breast cancer treatment delay differ for African American and White women. Cancer Epidemiol Biomarkers Prev 22(7):1227–1238PubMedPubMedCentralCrossRef McGee SA, Durham DD, Tse C-K, Millikan RC (2013) Determinants of breast cancer treatment delay differ for African American and White women. Cancer Epidemiol Biomarkers Prev 22(7):1227–1238PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98(9):1608–1615PubMedPubMedCentralCrossRef Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98(9):1608–1615PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Brady MJ, Cella DF, Mo F et al (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMedCrossRef Brady MJ, Cella DF, Mo F et al (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMedCrossRef
26.
Zurück zum Zitat Stern AF (2014) The hospital anxiety and depression scale. Occup Med 64(5):393–394CrossRef Stern AF (2014) The hospital anxiety and depression scale. Occup Med 64(5):393–394CrossRef
27.
Zurück zum Zitat Abu-Helalah M, Al-Hanaqta M, Alshraideh H, Abdulbaqi N, Hijazeen J (2014) Quality of life and psychological well-being of breast cancer survivors in Jordan. Asian Pac J Cancer Prev 15(14):5927–5936PubMedCrossRef Abu-Helalah M, Al-Hanaqta M, Alshraideh H, Abdulbaqi N, Hijazeen J (2014) Quality of life and psychological well-being of breast cancer survivors in Jordan. Asian Pac J Cancer Prev 15(14):5927–5936PubMedCrossRef
28.
Zurück zum Zitat Patoo M, Allahyari AA, Moradi AR, Payandeh M (2015) Persian version of Functional Assessment of Cancer therapy-Breast (FACT-B) scale: confirmatory factor analysis and psychometric properties. Asian Pac J Cancer Prev 16(9):3799–3803PubMedCrossRef Patoo M, Allahyari AA, Moradi AR, Payandeh M (2015) Persian version of Functional Assessment of Cancer therapy-Breast (FACT-B) scale: confirmatory factor analysis and psychometric properties. Asian Pac J Cancer Prev 16(9):3799–3803PubMedCrossRef
29.
Zurück zum Zitat Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1(1):1–7CrossRef Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1(1):1–7CrossRef
30.
Zurück zum Zitat Yost KJ, Eton DT (2005) Combining distribution-and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof 28(2):172–191PubMedCrossRef Yost KJ, Eton DT (2005) Combining distribution-and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof 28(2):172–191PubMedCrossRef
31.
Zurück zum Zitat Eton D, Cella D, Yost K, Yount S, Peterman A, Sledge G (2004) Minimally important differences on the Functional Assessment of Cancer Therapy-Breast (FACT-B) scale: results from ECOG study 1193. J Clin Epidemiol 57:898–910PubMedCrossRef Eton D, Cella D, Yost K, Yount S, Peterman A, Sledge G (2004) Minimally important differences on the Functional Assessment of Cancer Therapy-Breast (FACT-B) scale: results from ECOG study 1193. J Clin Epidemiol 57:898–910PubMedCrossRef
32.
Zurück zum Zitat Pinheiro LC, Tan X, Olshan AF et al (2017) Examining health-related quality of life patterns in women with breast cancer. Qual Life Res 26(7):1733–1743PubMedPubMedCentralCrossRef Pinheiro LC, Tan X, Olshan AF et al (2017) Examining health-related quality of life patterns in women with breast cancer. Qual Life Res 26(7):1733–1743PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Allott EH, Cohen SM, Geradts J et al (2016) Performance of three-biomarker immunohistochemistry for intrinsic breast cancer subtyping in the AMBER Consortium accuracy of protein and RNA-based breast cancer subtyping. Cancer Epidemiol Biomark Prev 25(3):470–478CrossRef Allott EH, Cohen SM, Geradts J et al (2016) Performance of three-biomarker immunohistochemistry for intrinsic breast cancer subtyping in the AMBER Consortium accuracy of protein and RNA-based breast cancer subtyping. Cancer Epidemiol Biomark Prev 25(3):470–478CrossRef
34.
Zurück zum Zitat Rubin DB (2004) Multiple imputation for nonresponse in surveys, vol 81. John Wiley & Sons, New York Rubin DB (2004) Multiple imputation for nonresponse in surveys, vol 81. John Wiley & Sons, New York
35.
Zurück zum Zitat Stuart EA, Azur M, Frangakis C, Leaf P (2009) Multiple imputation with large data sets: a case study of the Children’s Mental Health Initiative. Am J Epidemiol 169(9):1133–1139PubMedPubMedCentralCrossRef Stuart EA, Azur M, Frangakis C, Leaf P (2009) Multiple imputation with large data sets: a case study of the Children’s Mental Health Initiative. Am J Epidemiol 169(9):1133–1139PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D (2014) Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer 120(18):2902–2909PubMedCrossRef Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D (2014) Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer 120(18):2902–2909PubMedCrossRef
37.
Zurück zum Zitat Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 11(3):207–221PubMedCrossRef Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 11(3):207–221PubMedCrossRef
38.
Zurück zum Zitat Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA (1990) The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 65(5):1242–1254PubMedCrossRef Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA (1990) The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 65(5):1242–1254PubMedCrossRef
39.
Zurück zum Zitat Wenzel LB, Fairclough DL, Brady MJ et al (1999) Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 86(9):1768–1774PubMedCrossRef Wenzel LB, Fairclough DL, Brady MJ et al (1999) Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 86(9):1768–1774PubMedCrossRef
40.
Zurück zum Zitat Huynh V, Colborn K, Smith S et al (2021) Early trajectories of patient reported outcomes in breast cancer patients undergoing lumpectomy versus mastectomy. Ann Surg Oncol 28(10):5677–5685PubMedCrossRef Huynh V, Colborn K, Smith S et al (2021) Early trajectories of patient reported outcomes in breast cancer patients undergoing lumpectomy versus mastectomy. Ann Surg Oncol 28(10):5677–5685PubMedCrossRef
41.
Zurück zum Zitat Andruff H, Carraro N, Thompson A, Gaudreau P, Louvet B (2009) Latent class growth modelling: a tutorial. Tutor Quant Methods Psychol 5(1):11–24CrossRef Andruff H, Carraro N, Thompson A, Gaudreau P, Louvet B (2009) Latent class growth modelling: a tutorial. Tutor Quant Methods Psychol 5(1):11–24CrossRef
Metadaten
Titel
Emotional and functional well-being in long-term breast cancer survivorship
verfasst von
Yumeng Ren
Joanna Maselko
Xianming Tan
Andrew F. Olshan
Angela M. Stover
Antonia V. Bennett
Katherine E. Reeder-Hayes
Jessie K. Edwards
Bryce B. Reeve
Melissa A. Troester
Marc A. Emerson
Publikationsdatum
20.04.2024
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-024-01877-1

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.